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Dexmedetomidine (Dex), a highly selective α2-adrenoceptor agonist, attenuates
inflammatory responses induced by lipopolysaccharide (LPS) and induces sedative
and analgesic effects. Administration of Dex also reduces salivary secretion in human
subjects and inhibits osmotic water permeability in rat cortical collecting ducts.
However, little is known about the mechanisms underlying the effects of Dex on
salivary glands fluid secretion. We demonstrated the α2-adrenoceptor expression in
the basolateral membrane of mouse submandibular glands (SMG). To investigate fluid
secretion upon treatment with Dex, we studied the effects of Dex on the activity
of Na+-K+-2Cl− cotransporter1 (NKCC1) and Cl−/HCO−3 exchange (CBE), and on
downstream pro-inflammatory cytokine expression in isolated primary mouse SMG
cells. Dex acutely increased CBE activity and NKCC1-mediated and independent
NH+4 entry in SMG duct cells, and enhanced ductal fluid secretion in a sealed duct
system. Dex showed differential effects on cholinergic/adrenergic stimulations and
inflammatory mediators, histamine, and LPS, stimulations-induced Ca2+ in mouse SMG
cells. Both, histamine- and LPS-induced intracellular Ca2+ increases were inhibited
by Dex, whereas carbachol-stimulated Ca2+ signals were not. Long-lasting (2 h)
treatment with Dex reduced CBE activity in SMG and in human submandibular glands
(HSG) cells. Moreover, when isolated SMG cells were stimulated with Dex for 2 h,
phosphodiesterase 4D (PDE4D) expression was enhanced. These results confirm the
anti-inflammatory properties of Dex on LPS-mediated signaling. Further, Dex also
inhibitedmRNA expression of interleukin-6 andNADPH oxidase 4. The present study also
showed that α2-adrenoceptor activation by Dex reduces salivary glands fluid secretion
by increasing PDE4D expression, and subsequently reducing the concentration of cAMP.
These findings reveal an interaction between the α2-adrenoceptor and PDE4D, which
should be considered when using α2-adrenoceptor agonists as sedative or analgesics.
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INTRODUCTION
Dexmedetomidine (Dex) is a selective α2-adrenoceptor agonist
with sedative, analgesic, anxiolytic, and hemodynamic stabilizing
properties and has protective effects on systemic inflammation
by attenuating oxidative stress (Kiliç et al., 2012; Shen et al.,
2013). Several studies have shown that Dex benefits various
organs, including the heart (Okada et al., 2007; Kocoglu et al.,
2008), kidney (Liu et al., 2016), intestine (Sun et al., 2015), and
brain (Engelhard et al., 2002). Moreover, Dex exerts its protective
effects by inhibiting interleukin (IL)-1β-induced IL-6 synthesis
(Tanabe et al., 2014) and by reducing of lipopolysaccharide (LPS)-
induced production of pro-inflammatory cytokines, such as IL-
1β and IL-6 (Peng et al., 2013). Previously, we demonstrated
that Dex attenuated histamine-induced Ca2+ increase and IL-
6 expression in human salivary glands (HSG) cells (Yang
and Hong, 2015). Although, Dex reduces inflammation, there
are side effects associated with it, such as reduced salivary
secretion (Karhuvaara et al., 1991; Bischoff and Kochs, 1993)
and prevented hypersecretion (Marks et al., 2010). Monoxidine,
a α2-adrenoceptor and imidazole agonist, mediates salivary
glands vasoconstriction leading to hyposalivation (Moreira et al.,
2013). Activation of α2-adrenoceptors inhibits adenylate cyclase,
thereby reducing cAMP accumulation and cAMP-dependent
protein kinase signaling (Rabin et al., 1997).
Fluid secretion and transport are regulated by multiple inputs,
such as neurotransmitters-induced Ca2+ and cAMP levels in
acinar cells (Lee et al., 2012). However, little is known about the
regulatory effects of Dex on salivary glands function. Elevation of
Ca2+ levels by neuronal inputs, such as acetylcholine, stimulate
fluid secretion by increasing luminal eﬄux of Cl− through Ca2+-
activated Cl− channels. Cl− influx into the cytoplasm occurs
against its electrochemical gradient via the basolateral Na+-K+-
2Cl− co-transporter 1 (NKCC1) and via equivalent activities
of the Na+-H+ exchanger and the Cl−-HCO−3 exchanger (Lee
et al., 2012). HCO−3 transport in the salivary glands requires
basolateral HCO−3 input via the Na
+-HCO−3 co-transporter
and subsequent luminal HCO−3 output through solute carrier
transport 26 (SLC26) superfamily proteins, such as SLC26A6
(Lee et al., 2012; Jeong and Hong, 2016). The Ca2+ and cAMP
signaling pathways synergistically regulate fluid and HCO−3
secretion as a common signaling synergism (Lee et al., 2012;
Hong et al., 2014). Synergistic regulation of Ca2+ and cAMP
resulted in the activation of ion transporters, which induce
changes in intracellular pH (pHi; Park et al., 2013)
Phosphodiesterase (PDE) reduces intracellular cAMP and
cGMP concentrations (Omori and Kotera, 2007). In the salivary
glands, PDE4 is involved in the release of amylase from parotid
acinar cells (Satoh et al., 2009). The PDE4 inhibitor rolipram
regulates ductal HCO−3 secretion and confers a protective
effect on lipopolysaccharide (LPS)-induced Ca2+ signaling and
inflammatory cytokine expression (Lee et al., 2016). Although,
it has been suggested that Dex is involved in cAMP-mediated
cellular events (Rouch et al., 1997), it is unknown whether Dex-
modulation of cAMP levels plays a role in ion transporter activity
during salivary secretion or whether Dex modulates expression
of cAMP-dependent PDE4 of the salivary glands.
LPS is a characteristic component of the outer membrane
of Gram-negative bacteria, and LPS triggers innate immune
responses to wide range of pathogens by binding to Toll-like
receptor 4 (TLR4; Dauphinee and Karsan, 2006). Enhanced
expression of TLRs in salivary tissue is associated with
progression of inflammatory reactions in autoimmune diseases,
such as Sjögren’s syndrome (Spachidou et al., 2007). Moreover,
TLR activation triggered by LPS enhances oxidative signaling
(Liu et al., 2015). Oxidative stress is closely related to
inflammation, which is a risk factor in oral disease. It is
important that patients with chronic kidney disease report oral
complications, such as dry mouth (Ersson et al., 2011), as it may
be an indicator of salivary glands dysfunction due to oxidative
stress. The regulatory effects of Dex on ion transporters and on
fluid secretion from the salivary glands during LPS exposure
remain unclear.
We hypothesized that Dex could protect against LPS-induced
inflammatory signaling. Therefore, we investigated the anti-
inflammatory properties of Dex associated with Ca2+ signaling
in salivary glands acini and ductal cells upon exposure to
Porphyromonas gingivalis LPS. We also determined whether Dex
has regulatory effects on the ion transporters that mediate fluid
secretion and on the cAMP-PDE axis. An understanding of the
mechanisms underlying the reduced fluid secretion upon Dex
treatment may lead to innovative strategies for the treatment of
inflammation and salivary glands dysfunction during anesthesia
without additional unwanted side effects.
MATERIALS AND METHODS
Reagents and DNA Plasmids
Fura2-acetoxymethyl ester (Fura2-AM) and 2′,7′-bis-
(carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF)-AM
were purchased from Teflabs (Austin, TX). LPS from P.
gingivalis, histamine, Dexmedetomidine hydrochloride (Dex),
isoproterenol, carbamyl choline chloride (CCh), yohimbine
(YOH), bumetanide (Bumeta), and all other chemicals not
mentioned here were purchased from Sigma Aldrich (St. Louis,
MO). Pluronic F-127 (20% in DMSO) and ZO-1 antibody
were purchased from Invitrogen (Carlsbad, CA). PDE4 was
purchased from Fabgennix (Frisco, TX), and IL-6 and caspase-1
antibodies were purchased from Abcam (Cambridge, MA).
The α2A-adrenergic receptor antibody was purchased from
Santacruz Inc. (Santa Cruz, CA). Collagenase P was purchased
from Roche (Basel, Switzerland). The HA-tagged human AE2,
pCMV6-AC-mKate-SLC26A6, and empty vectors were kindly
provided by Dr. Shmuel Muallem (National Institutes of Health,
Bethesda, MD, USA).
Isolation of Mouse Submandibular Glands
Cells and Cultures of Parotid Sealed Ducts
and Human Salivary Glands Cell Lines
All procedures for maintaining the mice and for the isolation of
acini and ducts followed Gachon University guidelines and were
approved by the Animal Care and Use Committee of Gachon
University. Cultured, sealed parotid ducts from wild-type were
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prepared as described previously (Hong et al., 2015). SMG
isolated from 20 to 25 g wild-type mice were washed and
resuspended in physiological salt solution (PSS) A containing
140 mM NaCl, 10 mM glucose, 1 mM MgCl2, 5 mM KCl,
10 mM HEPES, and 1 mM CaCl2, pH 7.4, 0.02% STI, 0.1%
sodium pyruvate, and 0.1% BSA (called PSA) and kept on
ice until use. Briefly, the minced SMG was incubated in PSA
containing 2.5 mg/10 ml collagenase P (Roche) for 8 min at
37◦C. The digest was washed and resuspended with PSA, and
kept on ice until use. For the culture of sealed ducts, C57BL/6N
wild-type mice (20–25 g) were killed by cervical dislocation.
The parotid glands were removed and injected with a digestion
buffer consisting of serum-free DMEM, containing 50 U/ml
collagenase, 400 U/ml hyaluronidase, 0.2 mg/ml soybean trypsin
inhibitor (STI), and 2 mg/ml bovine serum albumin (BSA).
The tissue was minced and incubated at 37◦C for 30 min and
then in fresh digestion buffer for a further 45 min. After a
wash with DMEM containing 3% BSA and 0.2 mg/ml STI,
ducts were microdissected from the partially digested tissue to
remove acini or connective tissues. The ducts were cultured in
DMEM supplemented with 10% fetal bovine serum at 37◦C for
24 h before use. The HSG cells were purchased from American
Type Culture Collection (Rockville, MD) and maintained in
DMEM containing 10% FBS with antibiotics including 100
U/ml penicillin and 100 µg/ml streptomycin at 37◦C in a cell
culture incubator with 5% CO2/95% air atmosphere. When
cells were 70∼80% confluent, they were washed with PBS and
dispersed with a 2 min trypsin/EDTA treatment before they were
transferred to new culture dishes or glass coverslips-including
dishes for later use.
Measurement of Fluid Secretion by the
Sealed Ducts
Ductal fluid secretion was measured by video microscopy as
previously described (Yang et al., 2009; Hong et al., 2015).
Briefly, the sealed ducts were transferred to a poly-L-lysine-
coated perfusion chamber and perfused with HEPES- and then
HCO−3 -buffered media and stimulated with 5 µM forskolin
in HCO−3 -buffered media. Images were captured at 2 min
intervals, obtained up to 40 min, and analyzed by calculating
the lumen volume. Due to the variation in size between the
microdissected ducts, a normalized procedure was used with
the volume of the first image (V0) set as 1. Fluid secretion
was represented as the ratio Vt/V0, which was calculated from
Vt/V0 = (At/A0)
3/2.
DNA Transfection
Plasmid DNA transfection by Lipofectamine 2000 was followed
by manufacturer’s protocol (Invitrogen). Each plasmid DNA was
diluted in 250 µl of Opti-Eagle’s Minimum Essential Media
(Opti-MEMTM, Invitrogen), and 4 µl Lipofectamine 2000 was
diluted in 250 µl of the same medium and incubated for
5 min at room temperature. The DNAs and Lipofectamine
2000 were mixed and after 25 min were added to the cell-
cultured dish containing glass coverslip. After 4 h, the medium
was replaced with a fresh DMEM medium containing FBS
and the cells were used 24 h after the beginning of the
transfection.
Measurement of Intracellular Ca2+
Concentration
All procedures for mouse maintenance and for the isolation of
submandibular and parotid acini and ducts followed Gachon
University guidelines and were approved by the Animal Care and
Use Committee of Gachon University. Salivary glands isolated
from 25 to 30 g C57BL/6N mice were washed and re-suspended
in PSA and kept on ice until use. Briefly, minced salivary
gland cells were incubated in PSA containing 2.5 mg/10 ml
collagenase P for 8 min at 37◦C. The digest was washed with
PSA, re-suspended in PSA, and kept on ice until use. Cells were
transferred onto cover glasses and incubated with 4 µM Fura2-
AM in the presence of 0.05% Pluronic F-127 for 30 min in
PSS at room temperature, and then washed with PSS. Changes
in intracellular Ca2+ concentration ([Ca2+]i) were determined
by measuring the fluorescence intensities using dual excitation
wavelengths of 340 and 380 nm and an emission wavelength of
510 nm. Results are presented as fluorescence ratios (Ratio =
F340/380). The emitted fluorescence was monitored with a CCD
camera (Photometrics, AZ) attached to an inverted microscope
(Olympus, Japan) and analyzed with a MetaFluor system
(Molecular Devices, PA). Fluorescence images were obtained at
1 s intervals and background fluorescence was subtracted from
raw background signals at each wavelength.
Measurement of Cl−-HCO−3 Exchange
Activity and NH+4 Influx by pHi
Changes in pHi were measured with BCECF-AM at dual
excitation wavelengths of 440 and 495 nm and an emission
wavelength of 530 nm. Isolated SMG cells attached onto
coverslips were loaded in the chamber with 6 µM BCECF-
AM in the presence of 0.05% Pluronic F-127 for 15 min at
room temperature. After stabilizing the fluorescence, the cells
were perfused with PSS for at least 5 min before measuring
pHi at 37
◦C. CBE activity was measured by incubating the
cells with CO2-saturated HCO
−
3 -buffered media to acidify the
cytosol and initiated by perfusing the cells with Cl−-free HCO−3 -
buffered media. The emitted fluorescence was monitored with a
CCD camera (Photometrics) attached to an inverted microscope
(Olympus, Japan) and analyzed with a MetaFluor system
(Molecular Devices). All fluorescence images were obtained at
1 s intervals and background fluorescence was subtracted from
raw background signals at each wavelength. CBE activity was
determined from the derivatives of the slopes from the first 30–
45 s of pHi increases in Cl
−-free HCO−3 -buffered media. NH
+
4
influx was measured from the rate of pHi decrease induced by
intracellular uptake of NH+4 as previously described (Evans and
Turner, 1997; Worrell et al., 2004). Administration of NH4Cl
in the extracellular solution induced the initial alkalization by
diffusion of NH3, and then pHi is decreased by NH
+
4 influx as
a substitution of K+. The pHi recovery rate in second phase
provides NH+4 influx. The traces were normalized at time point
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of administration of NH4Cl. The acidified slope was calculated
and represented as the ratio.
Confocal Imaging
Experiments were performed with isolated SMG acinar and
ductal clusters. Isolated SMG acini and ducts were plated on
glass coverslips for 5 min at room temperature prior to fixation
with chilled methanol or 4% paraformaldehyde for 10 min.
After fixation, immunostaining was performed as described
previously (Lee et al., 2016) using 1:100 dilutions of the α2A-
adrenergic receptor, PDE4, and ZO-1 antibodies. Briefly, the
cells were incubated with the primary antibodies overnight
at 4◦C, then washed with 5% BSA/PBS. Remaining bound
antibodies were detected with goat anti-rabbit immunoglobulin
G (IgG) tagged with fluorescein isothiocyanate (FITC) (ZO-1)
or rhodamine (PDE4) and then washed with PBS. Coverslips
were mounted on glass slides with Fluoromount-GTM (Electron
Microscopy Sciences, Hatfield, PA) and analyzed using a LSM
700 Zeiss confocal microscope (Germany) with ZEN software.
To determine the normalized intensity of PDE4 in each image,
average intensity of PDE4 was divided by area. Images were
collected from four to five separate preparations of acinar and
ductal cells, and results are the averages from all experiments.
The absence of a primary antibody was used as a negative control
(NC). Fluorescent images were analyzed with a MetaMorph
system (Molecular Devices).
Semi-Quantitative Reverse
Transcription-Polymerase Chain Reaction
(Semi-qRT-PCR)
Total RNA was extracted from isolated SMG and HSG cells
using the Hybrid-RiboEx extraction system (Gentaur, Belgium)
following the manufacturer’s instructions, and amplified
according to the manufacturer’s protocol using TOPscriptTM
RT-PCR kit from Enzynomics (Daejeon, South Korea) and
nested primers. The primers used are listed in Table 1. The
PCR protocol comprised a denaturation step at 95◦C for 5 min,
followed by 35 cycles of 95◦C for 1 min, an annealing step for 1
min, and an extension step at 72◦C for 1 min, finally culminating
with a final extension step at 72◦C for 10 min. PCR products
were electrophoresed on 1% agarose gels. Bands on agarose gels
were visualized and acquired with a CCD camera and scanned
using GelDocXR imaging system (Bio-Rad, CA). Intensities of
PCR bands were analyzed with a MetaMorph system (Molecular
Devices).
Western Blot
SMG cells were isolated and stimulated with the indicated
components for 1 h. Cell lysates were prepared in lysis
buffer (containing [mM] 20 Tris, 150 NaCl, 2 EDTA, 1%
Triton X-100, and a protease inhibitor mixture) and treated
as previously described (Lee et al., 2016). Briefly, proteins
were denatured via incubation in SDS sample buffer at 37◦C
for 30 min. The 30 µg of denatured protein samples were
subjected to SDS-PAGE and transferred to methanol-soaked
polyvinylidene difluoride (PVDF) membranes. Transferred
proteins on PVDF membranes were visualized with PDE4
TABLE 1 | Information of primers.
Genes Tm (◦C) Sequences (5′ → 3′)
mPDE4A 55 (F) TTC AAG CTG CTG CAA GAA GA
(R) TTC CTG AGG ACC TGG ATA CG
mPDE4B 55 (F) GAA CAA ATG GGG CCT TAA CA
(R) TTG TCC AGG AGG AGA ACA CC
mPDE4C 57 (F) CAT GCT CAA CCG TGA GTT GT
(R) TGG AAC GTC TTG AGG AGG TC
mPDE4D 57 (F) GGA GCT TGT CAC CTT CTT GG
(R) GTG GGC TTT AAG TTG CTC CA
mGAPDH 55 (F) TTA GCC CCC CTG GCC AAG G
(R) CTT ACT CCT TGG AGG CCA TG
mIL-6 63 (F) GAG GAT ACC ACT CCC AAC AGA CC
(R) CTA TGG TAC TCC AGA AGA CCA GAG
mNOX2 57 (F) GTG TTG CTC GAC AAG GAT TC
(R) CTC CGA ATG GTT TTG GTA GAG
mNOX4 58 (F) CAG CTT CTA CCT ACG CAA TAA G
(R) GGA AAT GAG CTT GGA ACT TGG
hPDE4 62 (F) GTT GAG ACG AAG AAG GTG ACC AG
(R) GTC GGC CCA TGT TTC CCA CAA TG
hGAPDH 52 (F) GTC GGA GTC AAC GGA TT
(R) GCC ATG GGT GGA ATC ATA
(Fabgennix), α2A-adrenergic receptor (Santacruz), IL-6 and
caspase-1 (Abcam), and β-actin (Sigma) antibodies by enhanced
luminescence solution (Thermo Scientific).
Measurement of cAMP Concentrations
The cAMP concentration for each sample was determined by
cAMP EIA kit (Cayman Chemical Company, Ann Arbor, MI)
according to the manufacturer’s instructions. Briefly, absorbance
wavelength for assay was 405 nm, and cAMP concentration was
determined by calculation based on a standard curve. Protein
concentrations were measured by Quick Start Bradford Assay
(Bio-Rad, Hercules, CA). Each cAMP values were normalized to
amount of protein for each samples.
Statistical Analysis
Results from the indicated number of experiments were
expressed as mean ± SEM. Differences between means were
considered statistically significant when P < 0.01 (∗) or
P < 0.05 (#).
RESULTS
Effect of Dex on CBE Activity in Isolated
Mouse SMG Cells and Fluid Secretion in
Sealed Parotid Ducts
Mouse SMG tissue and isolated SMG cells were stained with
α2A-adrenoceptor antibody (Figures 1A,B). Protein expression
of α2A-adrenoceptor in SMG was evaluated by western blot
analysis (Figure 1C). We have demonstrated for the first that
the α2A-adrenoceptor is expressed in the basolateral membrane
of SMG cells. Then, to determine the effects of Dex on the
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FIGURE 1 | Effect of Dex on CBE activity in isolated mouse SMG cells and fluid secretion in sealed parotid ducts. (A,B) Localization of α2A-adrenergic
receptor (AR) in SMG tissue and isolated SMG acini. (C) Protein expression α2A-AR in SMG. CBE activity was determined by measuring changes in pHi in SMG acini
(D), SMG ducts (E), and parotid acini (F) with and without 100 ng/ml Dex. The slope of pHi measured CBE activity in the absence of Cl
− at the beginning of time
course (30–45 s), and height to reach the point of maximum pHi from the minimum point. Bars represent the mean ± SEM (n = 4, *p < 0.01, #p < 0.05). (G) Sealed
parotid ducts were isolated and used to measure fluid secretion in response to stimulation with 5 µM forskolin in the absence (control, open square) and presence of
100 ng/ml Dex (closed rhombus) (n = 4, *p < 0.01). (H) The mean ± SEM at the 40 min secretion time point shows an increase in basal secretion upon Dex treatment.
modulation of ion transporter activity, we measured CBE activity
in parotid, SMG acini, and SMG ductal cells. CBE activity was
evaluated by measuring the change in pHi induced by acute
Cl− removal and subsequent addition of Cl− in the presence or
absence of Dex. Removal of Cl− in the perfused solution induced
intracellular alkalization. The slope of the change in pHi was
measured using Cl−-free HCO−3 -buffered solution. No changes
in CBE activity were found in SMG and parotid acini cells upon
Dex treatment (Figures 1D–F), CBE activity in SMG ductal cells
was markedly increased upon acute Dex treatment (Figure 1E).
Our previous study suggested that CBE is essential for ductal
HCO−3 secretion in the salivary glands (Hong et al., 2015). The
clinical side effects of Dex such as hyposecretion raised the
question of whether Dex participates in modulation of HCO−3
transporters. To address this question, we measured ductal
fluid secretion using the sealed parotid ductal ex vivo system.
Interestingly, in contrast to the hyposecretion effect observed
clinically (Marks et al., 2010), Dex increased forskolin-stimulated
parotid ductal fluid secretion (Figure 1G). Dex-stimulated fluid
secretion at 40 min was 33.5 ± 11.2% higher than in the
control (Figure 1H). However, long-lasting Dex treatment for 2 h
showed no changes in ductal fluid secretion compared to control
(data not shown). These data suggest that CBE activity of ductal
cells and ductal fluid secretion were activated by acute treatment
with Dex.
Effect of Dex on NH+4 Influx in Mouse
Isolated SMG and HSG Cells
Fluid secretion is driven by the luminal Cl− eﬄux and the
basolateral Cl− influx that occurs across the plasma membrane
(Lee et al., 2012). The basolateral Cl− influx is mediated by
NKCC1. We measured NH+4 influx by measuring the change
in pHi during 20 mM NH4Cl pulse with and without Dex.
NH+4 influx increased in the presence of Dex in isolated SMG
acini, however, NH+4 influx decreased in the presence of the α2-
adreneric antagonist 10 µM yohimbine (YOH; Figures 2A,B).
A longer Dex treatment revealed no effect on NH+4 influx,
whereas, long-lasting YOH treatment (2 h) increased NH+4
influx (Figure 2B). HSG cells were also used to evaluate the
long-lasting Dex treatment on NH+4 influx. NH
+
4 influx was
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FIGURE 2 | Effect of Dex on NH+
4
influx in mouse isolated SMG and HSG cells. NH+4 influx was assessed by measuring changes in pHi in SMG acini with and
without 100 ng/ml Dex. The rate of NH+4 influx (gray dotted line) was determined from the pHi recovery rate in the second phase after 20 mM NH4Cl pulse. Bars
represent the mean ± SEM (n = 5). (A) Traces of the NH4Cl pulses used to measure NH
+
4 influx with 100 ng/ml Dex or 10 µM YOH in isolated SMG acini. (B) Analysis
of NH+4 influx in isolated SMG acini. Bars represent the mean ± SEM (n = 4, *p < 0.01). Analysis of NH
+
4 influx in HSG cells (C,D) and SMG acini (E) in the presence
of the indicated components including 100 µM Bumetanide (Bumeta). Bars represent the mean ± SEM (n = 4, *p < 0.01).
FIGURE 3 | Long-lasting Dex treatment on CBE activity in in mouse isolated SMG and HSG cells. SMG and HSG cells were treated with Dex for 2 h. CBE
activity was assessed by measuring changes in pHi in AE2-transfected cells (A), in SLC26A6-transfected cells (B), in SMG acini (C), and in HSG cells (D) with and
without 100 ng/ml Dex. Bars show the mean ± SEM (n = 4, *p < 0.01).
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increased in HSG cells upon acute Dex treatment, but was
partially inhibited with long- lasting Dex treatment for 2 h
(Figures 2C,D). Part of NH+4 influx is mediated by NKCC1
(Blanco et al., 2013). Bumetanide (Bumeta) is an inhibitor of
NKCC1. The minor effects of NH4+ entry observed with 10 µM
Bumeta (data now shown). The 100 µM Bumeta showed 52%
inhibition of NH4+ entry. Dex treatment partially restored the
Bumeta-associated NH+4 entry (Figure 2E). These data suggest
that NKCC1-independent NH+4 influx was activated by acute Dex
treatment with Dex, whereas, long-lasting Dex treatment did not
inhibit NH+4 entry.
Long-Lasting Dex Treatment on CBE
Activity in Mouse Isolated SMG and HSG
Cells
Although, Dex stimulates CBE activity andNH+4 entry, it remains
unclear how Dex induces fluid hyposecretion. We hypothesized
that the Dex effect was time-dependent, thus to evaluate the
long-lasting treatment with Dex, we measured CBE activity in
cells that were incubated with Dex for 2 h. To avoid isolated
SMG cells instability during the prolonged treatment period, we
employed a CBE overexpression system that included basolateral
anion exchanger 2 (AE2) and luminal solute carrier 26 family
SLC26A6 (Figures 3A,B). CBE activity in isolated SMG acini
and in HSG cells were inhibited by long-lasting Dex treatment
(Figures 3C,D), suggesting that Dex-induced inhibition of ion
transporters plays a role in fluid hyposecretion.
Differential Effects of Dex on
Neurotransmitter Inputs and Inflammatory
Mediator-Induced Intracellular Calcium
Signaling in Mouse SMG Cells
The fluid secretion function of the salivary glands is regulated
by numerous components, including neurotransmitters that
modulate spatial and temporal Ca2+ signaling (Lee et al.,
2016). The role of Dex on cholinergic/adrenergic inputs-induced
intracellular Ca2+ concentration ([Ca2+]i) increases was assessed
in SMG cells. Dex did not alter [Ca2+]i signals in SMG cells (data
not shown). SMG cells were stimulated with the β-adrenergic
agonist isoproterenol (Iso) and the cholinergic agonist carbamyl
choline chloride (CCh) with andwithout Dex (Figures 4A,B). No
effect of Dex stimulation was observed in CCh- and Iso-induced
[Ca2+]i signals. To evaluate whether the regulatory effect of Dex
in isolated SMG cells is mediated by inflammatory mediators,
such as histamine and LPS, histamine-, and LPS-induced
[Ca2+]i measurements were performed with and without Dex.
Inflammatory mediators-induced [Ca2+]i signals were inhibited
FIGURE 4 | Differential effects of Dex on neurotransmitter inputs and inflammatory mediator-induced intracellular calcium signaling in mouse SMG
cells. (A) Changes in [Ca2+]i induced by 100 µM isoproterenol without (closed circle) and with pre-treatment with 100 ng/ml Dex (open square). All of the traces were
averaged. (B) Changes in [Ca2+]i induced by 10 µM carbachol without (closed circle) and with pre-treatment with 100 ng/ml Dex (open square). All of the traces were
averaged. (C) Changes in [Ca2+]i induced by 100 nM histamine without (closed circle) and with pre-treatment with 100 ng/ml Dex (closed square). All of the traces
were averaged. (D) Changes in [Ca2+]i induced by 20 µg/ml LPS in ducts and in acini without (gray line for ducts and light gray line for acini) and with (black line)
pre-treatment with 100 ng/ml Dex. A single trace is shown. Arrows indicate when stimuli were applied to the cells.
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FIGURE 5 | Effect of Dex on PDE4 mRNA expression. (A) The mRNA expression of PDE4A–D subfamily members with and without 100 ng/ml Dex in SMG cells.
(B) Results are expressed as fold expression relative to the control and mean ± SEM (n = 3, *p < 0.01). (C,D) Time-dependent PDE4 mRNA expression with and
without 100 ng/ml Dex in HSG cells (n = 3, #p < 0.05).
by Dex (Figures 4C,D), thus Dex appears to play a role in
inflammatory mediators-induced Ca2+ signaling.
Effect of Dex on PDE4 Expression
Dex has been linked to post-cAMP activation cellular events
in the renal collecting duct (Rouch et al., 1997). PDE4, which
consists of four subfamilies, PDE4A-4D, is a well-characterized
cAMP-specific enzyme that is expressed in SMG cells (Lee et al.,
2016). To determine the effect of Dex on PDE4 expression
in SMG cells, we performed semi-qRT-PCR using cells treated
with Dex for 2 h. PDE4D mRNA expression increased in the
presence of Dex (Figures 5A,B). Dex-induced time-dependent
increase in PDE4 mRNA expression was also seen in HSG cells
(Figures 5C,D). We confirmed this Dex-induced stimulatory
effect by immunostaining isolated SMG cells with PDE4 antibody
(Figures 6A,C). As a specificity control, expression of the tight
junction marker ZO-1 did not change in the presence of Dex
(Figures 6B,C). We also found that PDE4 was dominantly
expressed in the luminal membrane of SMG cells and that
increased PDE4 expression was observed in Dex-treated SMG
cells. We confirmed the increase in PDE4 protein expression in
the presence of Dex for 2 h by an enhancement in the 65-kDa
band that corresponds to PDE4 (Figure 6D).
Dex-Induced Inhibition of LPS-Induced
Inflammatory Cytokine Expression and
cAMP Concentration
To evaluate the anti-inflammatory role of Dex on SMG cells, cells
were stimulated with LPS from P. gingivalis, and IL-6 expression
was measured. Previously, we found that SMG cells express
TLR4, which is involved in LPS signaling (Lee et al., 2016).
Dex inhibited LPS-induced IL-6 mRNA expression (#p < 0.05),
however, cytosolic and secreted IL-6 protein levels showed no
statistical difference (p < 0.1; Figures 7A,B).
NADPH oxidases (Nox) are a major source of reactive oxygen
species (ROS; Vieceli Dalla Sega et al., 2014), and LPS-induced
oxidative stress was found to increase production of ROS through
Nox4 (Ngkelo et al., 2012). Normal salivary glands cells express
Nox2 and Nox4 (Tateishi et al., 2008). We confirmed that
SMG cells expressed Nox2 and Nox4 mRNA and that Dex
attenuated Nox4, but not Nox2 mRNA expression in SMG cells
(Figures 7C,D). To further examine the anti-inflammatory role
of Dex, cells were stimulated with LPS and exposed to Dex.
The presence of enhanced bands at 65 and 102 kDa, which
correspond to PDE4A and PDE4D, respectively, in a Western
blot revealed increased PDE4 expression in LPS-stimulated cells
in the presence of Dex (Figures 7E,F).We obtained the enhanced
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FIGURE 6 | Effect of Dex on PDE4 expression. (A,B) Immunofluorescence staining of PDE4 (red) and ZO-1 (green) in isolated SMG cells. (C) Relative intensities of
PDE4 and ZO-1 staining divided by area. Bars represent the mean ± SEM (n = 3, *p < 0.01). NC, negative control. (D) PDE4 and β-actin protein expressions with
and without 100 ng/ml Dex in SMG cells.
bands at 65 and 102 kDa, respectively in the presence of Dex.
To confirm the effects of Dex on cAMP concentration, isolated
SMG cells were treated with Dex for various times (Figure 7G).
The activation of α2 adrenoceptors activates Gi protein, which
inhibits adenylate cyclase. Therefore, the activation of α2
adrenoceptors results in lower cAMP levels. Analysis of cAMP
concentration relative to time of Dex treatment indicated that 2
h of Dex treatment reduced cAMP levels in isolated SMG cells.
DISCUSSION
The major novel finding of the present study was that α2-
adrenoceptors are expressed in the basolateral membrane of
mouse SMG cells and that the selective α2-adrenoceptor
agonist Dex acutely increased ductal CBE activity and NKCC1-
independent NH+4 entry, as well as increased fluid secretion
in primary isolated SMG acini and ductal cells. Long-lasting
treatment (2 h) with Dex inhibited CBE activity but not
NH+4 entry. Reduced function of transporters caused by the
increased expression of PDE4, which may be involved in reduced
cAMP level in SMG. Recent evidence indicated that the α2-
adrenoceptor agonist Dex has anti-inflammatory properties in
various tissues (Peng et al., 2013; Tanabe et al., 2014; Yang
and Hong, 2015). In this study, we also demonstrated an
anti-inflammatory role for Dex in which Dex inhibits IL-6mRNA
and protein expression and Nox4 mRNA expression in LPS-
stimulated SMG cells.
A previous study demonstrated that the administration of Dex
induced low systolic and diastolic blood pressure even though an
initial blood pressure increase was observed (Karhuvaara et al.,
1991). Previously, we found that the PDE4 inhibitor rolipram
regulates intracellular cAMP levels and inhibits inflammatory
signaling in the salivary glands and that apical localization of
PDE4 may be involved in the activation of cAMP-dependent
secretion (Lee et al., 2016). Inhibition of PDE prevents cAMP
breakdown, increases intracellular cAMP concentrations, and
may lead to cardiac stimulation. However, Dex-mediated PDE-
sensitivity, as well as the differential roles and expression patterns
of each PDE subfamily member should be further investigated in
cardiac tissue and in the salivary glands.
HCO−3 transporters, including AE2 and SLC26A6, have been
shown to be required for cAMP-stimulated anion secretion
(Gawenis et al., 2010; Ahuja et al., 2014). Apical cAMP-associated
ion transporters localize to the PDE4-rich environment following
long Dex treatment, and this may induce impaired saliva
secretion. In the salivary glands, PDE activity varies depending
on intracellular cAMP concentrations due to salivary stimulation
during the tissue development (Tanaka et al., 2002). Although,
the cellular distributions and expression levels of PDE family
members in the salivary glands remain to be elucidated, the long
Dex-induced increase in PDE4D expression led to a reduction
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FIGURE 7 | Dex-induced inhibition of LPS-induced inflammatory cytokine expression and cAMP concentration. (A) SMG cells were stimulated with LPS,
treated with 100 ng/ml Dex, and then IL-6 mRNA and protein expression were measured in cell lysates (Lys) and cell supernatants (Sup). (B) Bars represent the mean
± SEM (n = 4, #p < 0.05). (C) LPS-induced Nox2 and Nox4 mRNA expression in the presence of 100 ng/ml Dex. (D) Analysis of Nox2 and Nox4 mRNA expression
in the presence of the indicated components (n = 5, *p < 0.01). (E) PDE4 protein expression in LPS-stimulated SMG cells. The arrowheads indicate PDE4A and
PDE4D bands at 65 and 102 kDa, respectively. (F) Analysis of PDE4 expression. Bars show the mean ± SEM (n = 4). (G) cAMP ratios in Dex-treated whole SMG
cells (n = 4, *p < 0.01).
in the function of the cAMP-dependent transporters NKCC
in acini and the Cl−/HCO−3 exchanger in ductal cells. To
our knowledge, this is the first demonstration of long-lasting
treatment with Dex-induced modulation of PDE4 expression.
It will be of particular interest to determine whether acute
stimulation of Dex requires signaling molecule to activate
transporters including AE2 and SLC26A6, activates other Cl−
transporters (e.g., cystic fibrosis transmembrane conductance
regulator), or activates directly (Figure 8). The prediction of
this model is that Dex may possess the dominant effect on Cl−
movement.
PDE4 functionally associates with the α2-adrenoceptor by
modulating intracellular levels of cAMP in noradrenergic
neurons (Robichaud et al., 2002). In this study, we provided
direct evidence that Dex modulates PDE4D expression. PDE4
activation has been found to be involved in a broad spectrum
of cellular events, for example, depletion of Nox4 decreases the
cAMP concentration and aquaporin 2 (AQP2) expression in a
PDE4-dependent manner in renal collecting duct principal cells
(Féraille et al., 2014). As shown in Figure 7C, administration of
Dex also inhibits Nox4 expression in SMG cells. As numerous
physiological roles have been attributed to Nox4 in various
tissues, a Nox4 deficiency as a result of long-lasting treatment
with Dex could associate with kidney and salivary glands
function, including AQP expression. PDE4 activation also
attenuates cardiomyocyte hypertrophy by inhibiting nuclear
PKA activity (Fan Chung, 2006).
The side effects of PDE4 inhibitors have been linked to PDE4-
related emesis (Robichaud et al., 2002). Although, it has been
difficult to define the role of PDE4 in emesis, activation of the
α2-adrenoceptor by Dex leads to enhanced expression of PDE4D
in the salivary glands.
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FIGURE 8 | Schematic model of Dex-modulated signaling. Dex, dexmedetomidine; α2A-AR, α2A-adrenoceptor; NKCC1, Na
+-K+-2Cl− cotransporter1; AE2,
anion exchanger2; SLC26A6, solute carrier 26 family A6; Nox4, NADPH oxidase 4; LPS, lipopolysaccharide; TLR4, toll-like receptor 4; PDE, phosphodiesterase;
YOH, yohimbine. Acute (black) and long-lasting (red) treatment with Dex.
This study suggests that activation of the α2-adrenoceptor
and Dex-mediated regulation of PDE4D play roles in salivary
signaling. Moreover, the cAMP/PDE4D axis is associated with
the microenvironment of the transporters in the salivary glands.
Thus, clearer understanding of PDE4-dependent/independent
cellular signaling in the salivary glands could prevent side effects,
such as fluid hyposecretion after operations and could prevent
choking on saliva during anesthesia.
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